After-hours 18:30 (ET)PLX Latest Quarter’s Earnings
Announce Date8/12/2026
EPS Actual (USD)0.05
Revenue Actual (USD)19.90M
Protalix Biotherapeutics Inc Earnings Dates & Reports
This page offers detailed Protalix Biotherapeutics Inc earnings data including the latest Protalix Biotherapeutics Inc earnings report, the upcoming Protalix Biotherapeutics Inc earnings date, historical data and Protalix Biotherapeutics Inc earnings call news.
PLX Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
PLX FY2025 Earnings
EPS (YoY)-0.08-308.02%
Revenue (YoY)52.74M-1.23%
Protalix Biotherapeutics Inc (PLX) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/12/2026 | 06/2026 | 0.05/-0.01 | 19.90M/12.93M | 572.20% | 53.86% |
| 5/13/2026 | 03/2026 | 0.23/-0.01 | 33.75M/11.47M | 2394.00% | 194.30% |
| 3/18/2026 | 12/2025 | -0.07/0.01 | 9.12M/14.36M | -1484.40% | -36.47% |
| 11/13/2025 | 09/2025 | 0.03/0.06 | 17.85M/17.87M | -46.00% | -0.08% |
| 8/14/2025 | 06/2025 | 0.00/0.03 | 15.66M/13.55M | -93.07% | 15.59% |
| 5/9/2025 | 03/2025 | -0.05/0.03 | 10.11M/21.60M | -257.47% | -53.18% |
| 3/17/2025 | 12/2024 | 0.09/0.07 | 18.22M/18.75M | 32.11% | -2.85% |
| 11/14/2024 | 09/2024 | 0.04/0.04 | 17.96M/16.26M | 10.00% | 10.46% |
Protalix Biotherapeutics Inc Latest Earnings Call Transcripts
Protalix BioTherapeutics (PLX) Q2 2026 Earnings Call: Elfabrio Drives Revenue Growth
Protalix BioTherapeutics Q2 2026 revenue rose 26.8% to $19.9 million as Elfabrio drove growth, while management reaffirmed its full-year outlook.